APA

Schmid C., Schleuning M., Hentrich M., Markl G. E., Gerbitz A., Tischer J., Ledderose G., Oruzio D., Hiddemann W. & Kolb H. (20080610). High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission. : Bone marrow transplantation.

Chicago

Schmid C, Schleuning M, Hentrich M, Markl G E, Gerbitz A, Tischer J, Ledderose G, Oruzio D, Hiddemann W and Kolb H-J. 20080610. High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission. : Bone marrow transplantation.

Harvard

Schmid C., Schleuning M., Hentrich M., Markl G. E., Gerbitz A., Tischer J., Ledderose G., Oruzio D., Hiddemann W. and Kolb H. (20080610). High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission. : Bone marrow transplantation.

MLA

Schmid C, Schleuning M, Hentrich M, Markl G E, Gerbitz A, Tischer J, Ledderose G, Oruzio D, Hiddemann W and Kolb H-J. High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission. : Bone marrow transplantation. 20080610.